Cargando…

European Headache Federation guideline on idiopathic intracranial hypertension

BACKGROUND: Idiopathic Intracranial Hypertension (IIH) is characterized by an elevation of intracranial pressure (ICP no identifiable cause. The aetiology remains largely unknown, however observations made in a number of recent clinical studies are increasing the understanding of the disease and now...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hoffmann, Jan, Mollan, Susan P, Paemeleire, Koen, Lampl, Christian, Jensen, Rigmor H, Sinclair, Alexandra J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Milan 2018
Materias:	Consensus Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6755569/ https://www.ncbi.nlm.nih.gov/pubmed/30298346 http://dx.doi.org/10.1186/s10194-018-0919-2

Ejemplares similares

European Headache Federation recommendations for neurologists managing giant cell arteritis
por: Mollan, S. P., et al.
Publicado: (2020)

Refractory chronic cluster headache: a consensus statement on clinical definition from the European Headache Federation
por: Mitsikostas, Dimos D, et al.
Publicado: (2014)

Neuromodulation of chronic headaches: position statement from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2013)

European headache federation consensus on technical investigation for primary headache disorders
por: Mitsikostas, D. D., et al.
Publicado: (2016)

Advances in the understanding of headache in idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2019)

Refractory chronic migraine: a Consensus Statement on clinical definition from the European Headache Federation
por: Martelletti, Paolo, et al.
Publicado: (2014)

Aids to management of headache disorders in primary care (2nd edition): on behalf of the European Headache Federation and Lifting The Burden: the Global Campaign against Headache
por: Steiner, T. J., et al.
Publicado: (2019)

European headache federation consensus on the definition of resistant and refractory migraine: Developed with the endorsement of the European Migraine & Headache Alliance (EMHA)
por: Sacco, Simona, et al.
Publicado: (2020)

European Headache Federation guideline on the use of monoclonal antibodies targeting the calcitonin gene related peptide pathway for migraine prevention – 2022 update
por: Sacco, Simona, et al.
Publicado: (2022)

Effect of exogenous estrogens and progestogens on the course of migraine during reproductive age: a consensus statement by the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESCRH)
por: Sacco, Simona, et al.
Publicado: (2018)

European Headache Federation (EHF) consensus on the definition of effective treatment of a migraine attack and of triptan failure
por: Sacco, Simona, et al.
Publicado: (2022)

Headache determines quality of life in idiopathic intracranial hypertension
por: Mulla, Yasmeen, et al.
Publicado: (2015)

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation
por: Bendtsen, Lars, et al.
Publicado: (2018)

European Headache Federation recommendations for placebo and nocebo terminology
por: Mitsikostas, Dimos D., et al.
Publicado: (2020)

Framing education on headache disorders into the Global Burden of Disease Study 2010. The European Headache Federation stands ready
por: Martelletti, Paolo, et al.
Publicado: (2013)

Idiopathic intracranial hypertension: consensus guidelines on management
por: Mollan, Susan P, et al.
Publicado: (2018)

European headache federation guideline on the use of monoclonal antibodies acting on the calcitonin gene related peptide or its receptor for migraine prevention
por: Sacco, Simona, et al.
Publicado: (2019)

Refractory Headache: One Term does Not cover All – A Statement of the European Headache Federation
por: Lampl, Christian, et al.
Publicado: (2014)

Hormonal contraceptives and risk of ischemic stroke in women with migraine: a consensus statement from the European Headache Federation (EHF) and the European Society of Contraception and Reproductive Health (ESC)
por: Sacco, Simona, et al.
Publicado: (2017)

Intracranial pressure directly predicts headache morbidity in idiopathic intracranial hypertension
por: Mollan, S. P., et al.
Publicado: (2021)

The expanding burden of idiopathic intracranial hypertension
por: Mollan, Susan P., et al.
Publicado: (2018)

Erenumab for headaches in idiopathic intracranial hypertension: A prospective open‐label evaluation
por: Yiangou, Andreas, et al.
Publicado: (2020)

Evaluation and management of adult idiopathic intracranial hypertension
por: Mollan, Susan P, et al.
Publicado: (2018)

Therapeutic lumbar puncture for headache in idiopathic intracranial hypertension: Minimal gain, is it worth the pain?
por: Yiangou, Andreas, et al.
Publicado: (2018)

Latest clinical recommendations on valproate use for migraine prophylaxis in women of childbearing age: overview from European Medicines Agency and European Headache Federation
por: Vatzaki, Efstratia, et al.
Publicado: (2018)

Structured headache services as the solution to the ill-health burden of headache: 1. Rationale and description
por: Steiner, Timothy J., et al.
Publicado: (2021)

Headache, Opiate Use, and Prescribing Trends in Women With Idiopathic Intracranial Hypertension: A Population-Based Matched Cohort Study
por: Adderley, Nicola Jaime, et al.
Publicado: (2022)

Emerging themes in idiopathic intracranial hypertension
por: Grech, Olivia, et al.
Publicado: (2020)

Novel advances in monitoring and therapeutic approaches in idiopathic intracranial hypertension
por: Mitchell, James L., et al.
Publicado: (2019)

Nuclear Magnetic Resonance Spectroscopy Metabolomics in Idiopathic Intracranial Hypertension to Identify Markers of Disease and Headache
por: Grech, Olivia, et al.
Publicado: (2022)

Understanding the link between obesity and headache- with focus on migraine and idiopathic intracranial hypertension
por: Westgate, Connar Stanley James, et al.
Publicado: (2021)

The methodology of population surveys of headache prevalence, burden and cost: Principles and recommendations from the Global Campaign against Headache
por: Stovner, Lars Jacob, et al.
Publicado: (2014)

Calcitonin gene related peptide monoclonal antibody treats headache in patients with active idiopathic intracranial hypertension
por: Yiangou, Andreas, et al.
Publicado: (2020)

Negative impact of COVID-19 lockdown on papilloedema and idiopathic intracranial hypertension
por: Thaller, Mark, et al.
Publicado: (2021)

Managing idiopathic intracranial hypertension in pregnancy: practical advice
por: Thaller, Mark, et al.
Publicado: (2022)

Metabolic Concepts in Idiopathic Intracranial Hypertension and Their Potential for Therapeutic Intervention
por: Hornby, Catherine, et al.
Publicado: (2018)

Consensus statement on the definition of neurogenic supine hypertension in cardiovascular autonomic failure by the American Autonomic Society (AAS) and the European Federation of Autonomic Societies (EFAS): Endorsed by the European Academy of Neurology (EAN) and the European Society of Hypertension (ESH)
por: Fanciulli, Alessandra, et al.
Publicado: (2018)

Reviewing the Recent Developments in Idiopathic Intracranial Hypertension
por: Virdee, Jasvir, et al.
Publicado: (2020)

Evolving evidence in adult idiopathic intracranial hypertension: pathophysiology and management
por: Mollan, Susan P, et al.
Publicado: (2016)

Current Perspectives on Idiopathic Intracranial Hypertension without Papilloedema
por: Mollan, Susan P., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_a5a2bvpvf8jg8mp3m322v2aok9